High Quality 99% Acalabrutinib CAS 1420477-60-6
TDS 4 Inquiries
1420477-60-6
Pharmaceutical Grade
99.5%
HANGZHOU
HyperChem
500g/ bag 25kg/ drum
Yes
2025-06-27
Pharmaceuticals,Peptide,Cosmetics,Nutritional Supplements
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial ReferenceAcalabrutinib (ACP-196) is a selective second-generation Bruton's tyrosine kinase (BTK) inhibitor with an IC50 of 3 nM, which prevents the activation of the B-cell antigen receptor (BCR) signaling pathway. ACP-196 has improved target specificity over ibrutinib with 323-, 94-, 19- and 9-fold selectivity over the other TEC kinase family members (ITK, TXK, BMX, and TEC, respectively) and no activity against EGFR.
ChEBI: Acalabrutinib is a member of the class of imidazopyrazines that is imidazo[1,5-a]pyrazine substituted by 4-(pyridin-2-ylcarbamoyl)phenyl, (2S)-1-(but-2-ynoyl)pyrrolidin-2-yl, and amino groups at positions 1, 3 and 8, respectively. It is an irreversible second-generation Bruton's tyrosine kinase (BTK) inhibitor that is approved by the FDA for the treatment of adult patients with mantle cell lymphoma (MCL) who have received at least one prior therapy. It has a role as an EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor, an antineoplastic agent and an apoptosis inducer. It is a secondary carboxamide, a member of benzamides, a member of pyridines, an aromatic amine, a pyrrolidinecarboxamide, an imidazopyrazine, a ynone and a tertiary carboxamide.
Class: non-receptor tyrosine kinaseTreatment: CLL, SLL, MCLOral bioavailability = 25%Elimination half-life = 0.9 hProtein binding = 97.5%CertificatesBasic Info-
Product Name:
Acalabrutinib
Other Name:ACP196;ACP-196;acalabrutinib;Benzamide, 4-[8-amino-3-[(2S)-1-(1-oxo-2-butyn-1-yl)-2-pyrrolidinyl]imidazo[1,5-a]pyrazin-1-yl]-N-2-pyridinyl-;ACP196,Acalabrutinib;4-[8-Amino-3-[(2S)-1-(1-oxo-2-butyn-1-yl)-2-pyrrolidinyl]imidazo[1,5-a]pyrazin-1-yl]-N-2-pyridinylbenzamide;EOS-60753;(S)-4-(8-amino-3-(1-but-2-ynoylpyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-N-(pyridin-2-yl)benzamide
CAS No.:1420477-60-6
Molecular Formula:C26H23N7O2
InChIKeys:WDENQIQQYWYTPO-IBGZPJMESA-N
Molecular Weight:465.51
Exact Mass:465.51
EC Number:814-272-0
Color/Form:Yellow
Categories:
Characteristics-
Density:
1.37±0.1 g/cm3(Predicted)
Melting Point:>133°C (dec.)
PKA:11.47±0.70(Predicted)
Critical Temperature & Pressure:Refrigerator
Hazard IdentificationClassification of the substance or mixture
Specific target organ toxicity â repeated exposure, Category 2
GHS label elements, including precautionary statements
Pictogram(s)
Signal word Warning
Hazard statement(s) H373 May cause damage to organs through prolonged or repeated exposure
Precautionary statement(s) Prevention P260 Do not breathe dust/fume/gas/mist/vapours/spray.
Response P319 Get medical help if you feel unwell.
Storage none
Disposal P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Pharmaceuticals,Peptide,Cosmetics,Nutritional Supplements
-
Location:
Rm. 803, Tower 4, LOFT49 Creative City Pioneer Zone, No.88 Jiru Rd. Gongshu Dist., Hangzhou, 310015 ZJ, China
-
Payment Terms:
TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
10 days
-
Total Annual Revenue:
$5 million-$10 million
-
Total Employees:
11-50
-
Year of Establishment:
2013
Company Certificates-
Certification Report by Bureau Veritas
-
-
Inquiry History4 Inquiries
Country Product Purchase Quantity Date Posted
India
ACALABRUTINIB
1 KG Jun 4, 2025
India
Acalabrutinib
11 KG Apr 21, 2025
Pakistan
Acalabrutinib
1 KG Jun 18, 2025
India
Acalabrutinib
10 KG Apr 14, 2025 Post an enquiry for this product
More from this Seller
-
-
-
API Ibuprofen
Pharmaceutical Grade / 99%
-
-
-
-
99% Assay Vardenafil CAS 224785-90-4 White Powder
Pharmaceutical Grade / 99%
-
-
-
-
Nilotinib CAS 641571-10-0 off-White Powder with Safe Shipping Anticacer
Pharmaceutical Grade / 99%
-
-
-
-
Urea 57-13-6 99% granular or power Urea
Pharmaceutical Grade / 99%
-
-
-
-
raw material Pro-xylane
Cosmetics Grade / 99%
-
